Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.768 USD | -4.00% | -17.44% | -5.19% |
May. 09 | HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Transcript : HOOKIPA Pharma Inc. - Special Call |
Financials (USD)
Sales 2024 * | 30.79M | Sales 2025 * | 11.82M | Capitalization | 75.99M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -85M | EV / Sales 2024 * | 2.47 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.43 x |
P/E ratio 2024 * |
-1.66
x | P/E ratio 2025 * |
-1.56
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.46% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | -4.00% | ||
1 week | -17.44% | ||
Current month | -13.45% | ||
1 month | -7.46% | ||
3 months | +13.51% | ||
6 months | +72.27% | ||
Current year | -5.19% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.768 | -4.00% | 623,571 |
24-05-09 | 0.8 | 0.00% | 600,841 |
24-05-08 | 0.8 | -3.26% | 536,263 |
24-05-07 | 0.827 | -6.05% | 843,946 |
24-05-06 | 0.8803 | -5.36% | 457,252 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.19% | 75.99M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- HOOK Stock